Subtotal $0.00
Shop Now
CBD drug interactions are documented, not theoretical. CBD (cannabidiol) is broken down in the liver by the same enzyme families that clear many prescription medicines, and it can slow several of those enzymes. That can push the level of another drug in the blood higher than intended. Published reports describe rising warfarin readings and rising transplant-drug levels in people taking CBD, and the FDA warns that CBD can affect how other drugs you take work, potentially causing serious side effects. If you take any prescription medicine, ask a pharmacist or prescriber before adding CBD.
Peptide Labs sells hemp-derived CBD products. This guide is general information as of September 30, 2026, not medical advice, and it cannot tell you whether CBD is safe with your own medicines.
Key Takeaways
- CBD is processed mainly by the liver enzymes CYP3A4 and CYP2C19, and the Epidiolex label says it can inhibit CYP2C19, CYP2C9, CYP2C8, CYP1A2 and others.
- Published cases include a warfarin patient whose INR rose from 2.2 to 6.9 and a transplant patient whose tacrolimus levels roughly tripled, both on prescription CBD.
- CBD combined with alcohol or other sedating drugs increases drowsiness, according to the FDA.
- The grapefruit-warning rule is a consumer rule of thumb, not an FDA rule for CBD, and it misses interactions through other enzymes.
- Bring the product label and its certificate of analysis to your pharmacist, and never change a prescription on your own.
How CBD drug interactions happen
Most interactions are about metabolism. According to the Epidiolex prescribing information, CBD is broken down mainly by two liver enzymes, CYP3A4 and CYP2C19, plus several UGT enzymes. At the same time, CBD can inhibit other enzymes at concentrations reached in people: CYP1A2, CYP2B6, CYP2C8, CYP2C9 and CYP2C19, along with UGT1A9 and UGT2B7. It may also affect P-glycoprotein (P-gp), a drug transporter: everolimus levels rose about 2.5-fold when taken with Epidiolex.
Interactions run in both directions. When CBD slows an enzyme, another medicine can build up. When another drug speeds up the enzymes that clear CBD, CBD levels fall; the antibiotic rifampin lowered CBD by about 32% and its active metabolite by 63%. Alcohol raised CBD exposure, increasing peak levels by 93%. A 2019 review in the Journal of Clinical Medicine described CBD as both a victim and a perpetrator of drug interactions and concluded that the potential for interactions with commonly used medicines is high.
What the Epidiolex label lists
Epidiolex, a purified CBD oral solution, is the only FDA-approved CBD drug, and its label is the most detailed interaction source available. It reflects prescription-strength amounts studied in patients; over-the-counter hemp products are not reviewed by the FDA and carry no such label. Key entries:
| Medicine or group | What was seen or predicted | Source |
|---|---|---|
| Clobazam (seizure medicine) | 3-fold rise in its active metabolite; sleepiness in 46% vs 16% without clobazam | Epidiolex label |
| Valproate | More liver enzyme elevations (ALT over 3x normal in 21% vs 3% on neither drug) | Epidiolex label |
| Diazepam and other CYP2C19 substrates | Higher blood levels | Epidiolex label |
| Everolimus; tacrolimus, sirolimus, digoxin | About 2.5-fold rise for everolimus; others may rise | Epidiolex label |
| Caffeine, theophylline, tizanidine | Possible increases (weak CYP1A2 inhibition) | Epidiolex label |
| Phenytoin; lamotrigine, morphine, lorazepam | Interactions predicted from lab data | Epidiolex label |
| Rifampin (strong enzyme inducer) | Lower CBD levels | Epidiolex label |
| Alcohol and other CNS depressants | More sedation and drowsiness | Epidiolex label; FDA |
| Warfarin | INR rose in a published case | Grayson 2018 case report |
CBD and blood thinners
Warfarin is the most thoroughly documented example. It has a narrow margin between too little and too much, it is cleared mainly by CYP2C9, and people who take it get regular INR blood tests. In a 2018 case report from the University of Alabama at Birmingham, a 44-year-old man with a mechanical heart valve had a stable INR of 2.0 to 2.6 for six months before joining an open-label program using prescription CBD. His target range was 2 to 3. As his CBD amount was increased, his INR climbed from 2.22 at baseline to 6.86 by day 28. His warfarin was lowered by about 30% over the following months, and he had no bleeding complications. The authors concluded that INR should be monitored when cannabinoids are introduced.
One case cannot show how often this happens, and the patient was taking prescription amounts. But the signal fits the enzyme data: the 2019 Journal of Clinical Medicine review lists warfarin among the CYP2C9 and CYP2C19 substrates to watch, and the antiplatelet drug clopidogrel among the CYP2C19 substrates. A 2024 systematic review in Frontiers in Pharmacology found 31 published reports of cannabinoid interactions with narrow-margin medicines and named warfarin among the most widely reported, with bleeding risk among the adverse effects. If you take any anticoagulant or antiplatelet medicine, talk to the clinic that manages it before starting or stopping CBD.
Transplant, seizure and other narrow-margin medicines
Tacrolimus, a transplant anti-rejection medicine, is the other widely cited case. In a 2019 report in the American Journal of Transplantation, a participant in a CBD epilepsy trial who was also taking tacrolimus had roughly a 3-fold increase in tacrolimus blood levels, adjusted for the amount taken, while on prescription-strength CBD. The same 2024 systematic review named tacrolimus, sirolimus, warfarin and valproate as the interactions most widely reported.
Researchers at Penn State published a list of 57 prescription medicines with a narrow therapeutic index that may be affected by cannabinoid use, and later built a free online screening tool called CANN-DIR. A Harvard Health blog post by a pharmacist-researcher named warfarin, the heart-rhythm medicine amiodarone, the thyroid medicine levothyroxine and several seizure medicines among the drugs with potentially serious CBD interactions. Most of this evidence comes from prescription CBD at high amounts. Interactions at the lower amounts on consumer labels are less studied, which makes the risk uncertain, not zero.
Sedation: CBD with alcohol, sleep aids and sedatives
Some interactions are about added effects rather than blood levels. The FDA says using CBD with alcohol or other drugs that slow brain activity, such as some anxiety, panic, stress or sleep medicines, increases the risk of sedation and drowsiness, which can lead to injuries. In Epidiolex trials, sleepiness was reported in 46% of patients also taking clobazam compared with 16% of those who were not, and the label advises against driving until you know how CBD affects you. Some CBD products also add other ingredients, such as melatonin, so read the full ingredient list.
Is there a CBD grapefruit warning?
Not officially. The so-called CBD grapefruit warning is a rule of thumb repeated in consumer health articles: if your medicine carries a warning about grapefruit, avoid CBD or ask first. The logic is partly sound. The FDA explains that grapefruit juice blocks CYP3A4 in the small intestine, so more of certain drugs reaches the blood, and CYP3A4 is one of the enzymes involved in CBD metabolism. But no FDA rule puts a grapefruit-style warning on hemp CBD products, and the heuristic has two blind spots.
- It misses other pathways. The clearest interaction on the Epidiolex label, with clobazam, runs through CYP2C19, and warfarin is cleared mainly by CYP2C9. Neither route is what grapefruit mainly blocks.
- It proves nothing by itself. A grapefruit warning suggests a medicine is sensitive to CYP3A4 changes, but it does not show that CBD will change that medicine’s levels in you.
Use the grapefruit warning as a prompt to ask your pharmacist, never as a green light when it is absent.
How to check CBD interactions with medications
- List everything you take: prescriptions, over-the-counter medicines, supplements and any other hemp products.
- Show your pharmacist the actual CBD product and its batch certificate of analysis. Labels are not always accurate: a 2017 JAMA study found only 31% of 84 CBD products within 10% of the labeled CBD amount. Our guide on how to read a CBD certificate of analysis shows what to look for.
- Ask whether blood tests such as INR, drug levels or liver tests make sense when you start or stop CBD. The Epidiolex label calls for liver tests before starting, and valproate raises the liver risk.
- Do not stop or change a prescription medicine on your own because you started CBD.
- Avoid driving or alcohol until you know how the combination affects you.
Spectrum matters too. Full-spectrum products contain some THC, which uses overlapping liver enzymes and can show up on a drug test; see our guides to CBD vs THC and whether CBD shows up on a drug test. Label warnings are worth reading as well. The cbdMD Broad Spectrum CBD Oil Tincture label, for example, says not to combine it with alcohol or medications and to consult a medical professional first if you take medication. You can compare labels and lab reports across our CBD category, and our CBD gummies vs oil guide covers how form affects absorption.
Frequently Asked Questions
Can CBD interact with medications?
Yes. CBD is broken down by liver enzymes that many medicines also use, and it can slow several of them. The FDA warns that CBD can affect how other drugs work and cause serious side effects.
Is CBD safe to take with blood thinners?
It has not been shown to be safe. A published case described a warfarin patient whose INR rose above the target range after starting prescription CBD. Talk to the clinic that manages your blood thinner before using CBD.
Should I follow the grapefruit warning rule for CBD?
Use it only as a prompt to ask a pharmacist. It is not an FDA rule, and some documented CBD interactions involve enzymes that grapefruit does not mainly affect.
Does CBD interact with alcohol?
Alcohol and CBD together can increase drowsiness, and in Epidiolex studies alcohol also raised CBD blood levels. Avoid driving if you combine them.
Do small amounts of CBD cause interactions?
Most interaction data come from prescription-strength CBD. Lower amounts are less studied, so the risk is uncertain rather than absent. A pharmacist can review your specific medicines.
Does full-spectrum CBD add any extra concerns?
Full-spectrum products contain some THC, which is metabolized by overlapping liver enzymes and can cause a positive drug test. Check the certificate of analysis for THC content.
This article is general information as of September 30, 2026, not medical advice. Questions? Contact us. CBD products sold at Peptide Labs are hemp-derived and are not FDA-approved drugs. The FDA has not approved CBD as a dietary supplement or food ingredient, and hemp product rules vary by state. Check your state’s rules, follow each product label and talk to a healthcare provider before using CBD if you take medicines, are pregnant or nursing, or have a medical condition.
Last reviewed September 2026.
Related guides: CBD vs THC: Chemistry, the High, Legal Status, Drug Tests and Safety, How to Read a CBD Certificate of Analysis (COA), Does CBD Show Up on a Drug Test?, Turmeric Side Effects: Liver Injury, Interactions and Turmeric vs Curcumin.